Suppr超能文献

[内科疾病中的碳水化合物输注。代谢健康患者、肝病患者和糖尿病患者的比较研究。I. 单糖肠外给药的生理病理方面]

[Carbohydrate infusion in internal diseases. A comparative study in metabolically healthy patients, patients with liver diseases and diabetic patients. I. Physiopathologic aspects in the parenteral administration of monosaccharides].

作者信息

Luft D

出版信息

Infusionsther Klin Ernahr. 1981 Aug;8(4):163-71.

PMID:6792074
Abstract

The biochemical basis of the metabolism of glucose and non-glucose-carbohydrates (fructose, sorbitol, xylitol) is presented. The potential draw backs of the parenteral application of large doses of these carbohydrates in internally ill patients, based on the results of experiments with isolated perfused livers or animals and case reports, are reviewed. These considerations form the basis for investigations in internally ill patients (liver cirrhosis, diabetes mellitus) and healthy controls in order to find out if low dose, long term, parenteral infusion of glucose or mixtures of glucose with non-glucose-carbohydrates are applicable to these patients without major side effects. The results of these investigations will be published in following papers.

摘要

本文介绍了葡萄糖和非葡萄糖碳水化合物(果糖、山梨醇、木糖醇)代谢的生化基础。基于离体灌注肝脏或动物实验结果及病例报告,综述了内科疾病患者大剂量肠外应用这些碳水化合物可能存在的弊端。这些考量为针对内科疾病患者(肝硬化、糖尿病)及健康对照进行研究奠定了基础,旨在探究低剂量、长期肠外输注葡萄糖或葡萄糖与非葡萄糖碳水化合物的混合物对这些患者应用时是否无严重副作用。这些研究结果将在后续论文中发表。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验